Form 4: Agilon Health Executive Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Agilon Health's Chief Legal Officer, Denise Zamore, reported transactions involving the acquisition of 50,000 restricted stock units and the withholding of 1,024 shares for tax obligations.
Summary
- Denise Zamore, Chief Legal Officer of Agilon Health, Inc., reported transactions on April 1, 2026.
- Zamore acquired 50,000 restricted stock units (RSUs) with no cost, vesting in three equal annual installments starting April 1, 2026, contingent on continued employment.
- Additionally, 1,024 shares of common stock were withheld by the issuer to cover tax obligations related to the net settlement of RSUs.
- Following these transactions and a 1-for-25 reverse stock split effective March 30, 2026, Zamore beneficially owns 66,837 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine executive compensation and tax-related share withholding, without significant positive or negative financial implications presented.
Positives
- Acquisition of 50,000 restricted stock units by a key executive, indicating continued incentive and potential future value.
- The vesting schedule for RSUs aligns with continued employment, promoting executive retention.
Negatives
- Withholding of 1,024 shares for tax purposes, representing a reduction in the net shares received by the executive.
Risks
- The filing does not explicitly mention any new risks. However, the value of the RSUs is subject to the future performance and stock price of Agilon Health.
Future Outlook
The restricted stock units acquired by Denise Zamore are set to vest in three equal installments on each anniversary of April 1, 2026, subject to her continued employment with Agilon Health.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The acquisition of RSUs by a Chief Legal Officer is typical for executive compensation and retention strategies within the healthcare services sector, particularly for companies like Agilon Health focused on value-based care models.
Stakeholder Impact
- Shareholders: The transaction itself does not represent a sale of stock by an insider, but rather an acquisition of equity-based compensation and a tax-related withholding. The overall impact on share price is likely minimal based on this filing alone.
- Employees: The RSU grant to the Chief Legal Officer aligns with common executive compensation practices, potentially influencing employee morale and retention strategies.
- Management: The transaction reflects standard executive compensation and tax management practices.
Next Steps
- Continued employment by Denise Zamore to satisfy RSU vesting conditions.
- Future vesting of restricted stock units on April 1, 2027, and April 1, 2028.
Key Dates
| Date | Description |
|---|---|
| 03/30/2026 | Effective date of the 1-for-25 reverse stock split. |
| 04/01/2026 | Date of reported stock transactions (acquisition of RSUs and tax withholding). |
| 04/01/2026 | First vesting installment date for the newly acquired restricted stock units. |
| 04/02/2026 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
Form 4, SEC Filing, Agilon Health, Denise Zamore, Stock Transaction, Restricted Stock Units, Beneficial Ownership, Insider Trading, Executive Compensation, AGL
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.